Telaglenastat
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Telaglenastat, covering 2017-01-04 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1]